Navigation Links
Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation

MURRYSVILLE, Pa., Nov. 6 /PRNewswire/ -- Philips Respironics applauds the efforts of the Centers for Disease Control and Prevention (CDC) to raise awareness about an important public health issue -- chronic sleep insufficiency. The CDC's release of the first-ever government study to monitor state-by-state differences in sleeplessness is a milestone in quantifying the size and scope of the problem.

As a long-time educator, industry leader and sleep therapy manufacturer, Philips Respironics supports government efforts to draw attention to chronic sleep insufficiency, which remains under-reported and under-treated despite being associated with numerous physical and mental health problems, injury and mortality. It is estimated that 50 to 70 million Americans chronically suffer from a disorder of sleep and wakefulness, hindering daily functioning and adversely affecting their health and longevity.

Sleep - along with diet and exercise - is the third leg of the stool of good health. Nothing would have greater impact in reducing the health and safety toll of chronic sleep deprivation than the CDC's recommendation that healthcare providers consider adding an assessment of chronic rest or sleep insufficiency to routine office visits

Philips Respironics is dedicated to helping diagnose and improve the quality of life for Americans who experience sleep disorders. In 1985 we were the first company to commercialize continuous positive airway pressure (CPAP) therapy for treating Obstructive Sleep Apnea (OSA), a condition where a person's airway collapses repeatedly during sleep, preventing proper respiration and adequate rest. Today, CPAP therapy is the first-line of treatment for millions of OSA sufferers.

Sleep apnea is one of the world's most common sleep disorders, linked to a host of health problems including hypertension, insulin resistance, and increased risk of heart attack, stroke, and heart failure. We look forward to working with the government to educate Americans about sleep, sleep disorders, and the consequences of sleep deprivation.

SOURCE Philips Healthcare

SOURCE Philips Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
2. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
3. PhRMA Statement on Senate Finance Committee Vote
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
6. EAU Position Statement on Screening for Prostate Cancer
7. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
8. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
9. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
10. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
11. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Research . --> Clinical Cancer Research . ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... Aliso Viejo, CA (PRWEB) , ... November 26, ... ... X users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. ... custom style options. These classically-influenced trailer titles work with any font, giving users ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a ... ™ attracts volunteers together who want to combine talents and resources to help ... in the process. The non-profit launched its first major fundraiser on November 6, ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... ... launched offering factory direct sauna parts and accessories. , Sauna accessories help ... of the bather’s style and personality. From basic styles for the purist looking ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
Breaking Medicine News(10 mins):